Co je nového v doporučeních ESC 2021 pro kardiovaskulární prevenci?
[Whats new in 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice?]
Language Czech Country Czech Republic Media print
Document type Journal Article
PubMed
36283820
DOI
10.36290/vnl.2022.063
PII: 132183
- Keywords
- SCORE2 and SCORE2-OP, atherosclerotic cardiovascular disease, cardiovascular risk factors, doppler ultrasound of uterine artery, healthy lifestyle, prevention, treatment,
- MeSH
- Atherosclerosis * drug therapy MeSH
- Cardiology * MeSH
- Cardiovascular Diseases * epidemiology MeSH
- Cholesterol, LDL MeSH
- Humans MeSH
- Risk Factors MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors * therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Cholesterol, LDL MeSH
- Hydroxymethylglutaryl-CoA Reductase Inhibitors * MeSH
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice provides a comprehensive view on preventive cardiology. It presents strategies to reduce the burden of atherosclerotic cardiovascular disease (CVD), both at the individual level and at the population level. Healthy lifestyle and aggressive control of cardiovascular risk factors remain the cornerstone of prevention. Classification of individuals into risk groups based on their clinical characteristics followed by a stepwise treatment-intensification is a novel recommended approach. Updated risk charts - SCORE2 and SCORE2-OP - are intended for estimation of 10-year fatal and non-fatal CVD risk in apparently healthy individuals. Targets and goals for LDL cholesterol, blood pressure, and glycaemic control remain as recommended in recent ESC Guidelines.
References provided by Crossref.org
